Company: AVCRF
Filing Date: 2025-06-16
Form Type: 20-F
Source: 0001641172-25-015266
Chunk: 21

Company: Avricore Health Inc.
Filing Date: 2025-06-16
Form: 20-F
Item: Item 6
Chunk 21
---
 counsel the Board of
Directors of the Company and to channel to the Company all knowledge, business and customer contacts and any other information that could
concern or be in any way beneficial to the Company. All information communicated to the Company will be the property of the Company.
The Officers acknowledge that each is a “person in a special relationship”, as that expression is defined in the securities
laws of various provinces of Canada, and may receive material information concerning the business and affairs of the Company that has
not been generally disclosed, and covenant and agree that they will not purchase or sell any securities of the Company until such information
has been generally disclosed. The Company is aware that the Officers may provide services to certain other companies from time to time
as disclosed above. The Officers agree that they will not provide services to any other companies without the written approval of the
Company.

The
Company will pay a consulting fee in the amount of (Cdn) $18,000 per month to Hector Bremner for CEO services through a consulting agreement.

The
Company will pay a consulting fee in the amount of (Cdn) $10,700 per month to a company controlled by Kiki Smith for CFO and Corporate
Secretarial services through a consulting agreement.

The
Company will pay a consulting fee in the amount of (Cdn) $18,000 per month to Rodger Seccombe for CTO services through a consulting agreement.

The
fees payable will be reviewed annually, and may be adjusted by the Company in consultation with the Officers to reflect general economic
conditions, changes in the duties provided under this Agreement or performance by the Officers. The Officers are entitled to participate
in the Company’s incentive stock option plan (Exhibit 4. m).

Inventions
of any type made by the Officers become the sole property of the Company which will hold all intellectual property rights for such inventions.
If the Company chooses to patent, copyright, trademark or otherwise protect the inventions, the Officers will assign their rights to
the Company. The Officers will treat all information of the company as confidential except any information that is presently in the public
domain, any information that subsequently becomes part of the public domain, any information obtained by the Officers from a third party
with a valid right to disclose it or any information that was independently developed by the Officers or was in their possession prior
to receipt from the Company.

The
Officers agree that they shall not engage in any activity that is contrary to or detracts from the performance of